Deutsche Bank Ag\ Neuro Pace Inc Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Neuro Pace Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 924,274 shares of NPCE stock, worth $9.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

924,274

Previous 412,612 124.01%

Holding current value

$9.68 Million

Previous $4.62 Million 146.03%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$10.04 - $14.94 $5.14 Million - $7.64 Million	511,662 Added 124.01%	924,274 $11.4 Million
Q4 2024 Feb 14, 2025	BUY	$5.9 - $11.93 $2,100 - $4,247	356 Added 0.09%	412,612 $4.62 Million
Q3 2024 Jun 26, 2025	SELL	$6.65 - $8.46 $3.4 Million - $4.33 Million	-512,018 Reduced 55.4%	412,256 $2.87 Million
Q3 2024 Nov 13, 2024	SELL	$6.65 - $8.46 $1.61 Million - $2.04 Million	-241,429 Reduced 36.93%	412,256 $2.87 Million
Q2 2024 Jun 12, 2025	SELL	$6.38 - $15.33 $1.73 Million - $4.15 Million	-270,589 Reduced 29.28%	653,685 $4.94 Million
Q2 2024 Aug 14, 2024	BUY	$6.38 - $15.33 $4.17 Million - $10 Million	653,685 New	653,685 $4.94 Million
Q2 2022 Aug 11, 2022	SELL	$4.95 - $8.7 $19,092 - $33,555	-3,857 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.06 - $11.57 $3,247 - $5,322	-460 Reduced 10.66%	3,857 $32,000
Q4 2021 Feb 11, 2022	BUY	$8.63 - $17.36 $1,984 - $3,992	230 Added 5.63%	4,317 $44,000
Q3 2021 Nov 04, 2021	SELL	$15.85 - $25.07 $729 - $1,153	-46 Reduced 1.11%	4,087 $65,000
Q2 2021 Aug 11, 2021	BUY	$19.03 - $26.5 $78,650 - $109,524	4,133 New	4,133 $98,000

Others Institutions Holding NPCE

# of Institutions

Shares Held

29.9M

Call Options Held

1.8K

Put Options Held

300

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $260M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account